BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32236910)

  • 1. Comment on "Levothyrox
    Hoermann R; Midgley JEM; Larisch R; Dietrich JW
    Clin Pharmacokinet; 2020 May; 59(5):655-657. PubMed ID: 32236910
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Levothyrox
    Yu Y; Maliepaard M
    Clin Pharmacokinet; 2020 Feb; 59(2):281-282. PubMed ID: 31802403
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: "Levothyrox
    Lechat P; Ropers J; Barré J; Mouly S
    Clin Pharmacokinet; 2019 Oct; 58(10):1351-1352. PubMed ID: 31452152
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: Levothyrox
    Tréchot P
    Clin Pharmacokinet; 2019 Jul; 58(7):977-978. PubMed ID: 31187471
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on "Levothyrox
    Munafo A; Krebs-Brown A; Gaikwad S; Urgatz B; Castello-Bridoux C
    Clin Pharmacokinet; 2019 Jul; 58(7):969-971. PubMed ID: 31187469
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: "Levothyrox
    Coste J; Bertagna X; Zureik M
    Clin Pharmacokinet; 2019 Jul; 58(7):965-966. PubMed ID: 31161457
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: "Levothyrox
    Nicolas P
    Clin Pharmacokinet; 2019 Jul; 58(7):959-960. PubMed ID: 31161454
    [No Abstract]   [Full Text] [Related]  

  • 8. Author's Reply to Trechot: "Comment on Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):979-980. PubMed ID: 31187472
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors' Reply to Castello-Bridoux et al.: "Comment on Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):973-975. PubMed ID: 31187470
    [No Abstract]   [Full Text] [Related]  

  • 10. Authors' Reply to Yu et al.: "Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2020 Feb; 59(2):283-285. PubMed ID: 31802402
    [No Abstract]   [Full Text] [Related]  

  • 11. Authors' Reply to Lechat et al.: "Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Oct; 58(10):1353-1354. PubMed ID: 31452151
    [No Abstract]   [Full Text] [Related]  

  • 12. Authors' Reply to Coste et al.: "Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):967-968. PubMed ID: 31161455
    [No Abstract]   [Full Text] [Related]  

  • 13. Authors' Reply to Nicolas: "Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):961-963. PubMed ID: 31161456
    [No Abstract]   [Full Text] [Related]  

  • 14. The French Levothyrox
    Mouly S; Roustit M; Bagheri H; Perault-Pochat MC; Molimard M; Bordet R
    Therapie; 2019 Jun; 74(3):431-435. PubMed ID: 30737052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lévothyrox
    Wémeau JL; Ladsous M
    Presse Med; 2017 Oct; 46(10):887-889. PubMed ID: 29108724
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox
    Viard D; Parassol-Girard N; Romani S; Van Obberghen E; Rocher F; Berriri S; Drici MD
    Fundam Clin Pharmacol; 2019 Aug; 33(4):463-470. PubMed ID: 30575110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levothyrox crisis].
    Bertagna X; Bouchard P; Grimaldi A; Wemeau JL; Young J; Rodien P; Reynaud R; Noël C; Bapt G
    Rev Prat; 2019 Sep; 69(7):721-728. PubMed ID: 32233310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Levothyrox : time of reason].
    Bertagna X; Bouchard P; Grimaldi A; Wémeau JL; Young J
    Rev Prat; 2018 Feb; 68(2):123-125. PubMed ID: 30801135
    [No Abstract]   [Full Text] [Related]  

  • 19. Is levothyroxine requirement the same for tablet and soft gel formulations?
    Di Donna V; Paragliola RM; de Waure C; Papi G; Pontecorvi A; Corsello SM
    Endocrine; 2018 Feb; 59(2):458-460. PubMed ID: 28466401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Are the two formulas of Levothyrox bioequivalent?].
    Coste J; Bertagna X; Zureik M; Nicolas P; Ramez P; Hill C; Schlumberger M
    Rev Prat; 2019 Oct; 69(8):831-837. PubMed ID: 32237644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.